Skip to main content

Table 2 Patient background and disease-related characteristics collected at time of inclusion

From: Axial spondyloarthritis and breastfeeding: a prospective study

Number of included births in the study

n

 

Age, mean (SD)

417

30.7 (4.5) 

 Age ≥ 35 years (%)

 

82 (19.7) 

 Missing

0

 

Previous live birth (%)

390

206 (52.8) 

 Missing

27

 

Pregnant (%)

417 

270 (64.7) 

 Missing

0

 

BMI kg/m2 mean (SD)

401 

25.7 (4.8) 

 Underweight (< 18.5) (%)

 

4 (1.0) 

 Normal weight (18.5–24.9) (%)

 

206 (51.4)

 Overweight (≥ 25.0) (%)

 

191 (47.6) 

 Obesity (≥ 30.0) (%)

 

73 (18.2)

 Missing

16

 

Tobacco a (%)

375 

33 (8.8) 

 Missing

42

 

Educational level b (%)

407

 

 Low

 

8 (2.0)

 Intermediate

 

114 (28.0)

 High

 

285 (70.0) 

 Missing

10

 

Working fulltime or part-time (%)

408 

309 (75.7)

 Missing

9

 

Exercising regularlyc(%)

306

218 (71.2) 

 Missing

111

 

Living situation

403 

 

 Living with someone (%)

 

390 (96.8)

 Living alone (%)

 

13 (3.2)

 Missing

14

 

Disease related characteristics

Disease duration, years, mean (SD)

380 

4.5 (3.9) 

 Missing

37

 

Classification criteria met (%)

417 

389 (93.3) 

 Missing

0

 

HLA-B27 positive (%)

340

271 (79.7)

 Missing

77

 

CRP mg/L mean (SD)

382

5.8 (7.1)

 CRP ≥ 5 (%)

 

140 (36.6)

 Missing

35

 

BASDAI, mean (SD)

348

3.4 (2.3) 

 BASDAI ≥ 4 (%)

 

132 (37.9)

 Missing

69

 

 ASDAS-CRP, mean (SD)

253

2.2 (0.9) 

 ASDAS-CRP ≥ 1.3 (%)

 

206 (81.4) 

 Missing

164

 

VAS scores (0–100 mm) mean (SD)

 Pain

341

32.4 (25.1) 

 Missing

76

 

 Fatigue

328 

50.0 (30.7) 

 Missing

89

 

 Total

339

35.8 (25.7) 

 Missing

78

 

Medications

 csDMARDs (%)

417 

27 (6.5) 

 Sulfasalazine

 

22 (5.3) 

 Methotrexate

 

5 (1.2) 

 Missing

0

 

TNF-inhibitors (%)

417 

116 (27.8) 

 Missing

0

 

Secukinumab (%)

417 

0 (0.0) 

 Missing

0

 
  1. n number of available data on variable, BMI body mass index, HLA human leukocyte antigen, CRP C-reactive protein, VAS visual analogue scale, BASDAI bath ankolysing spondylitis disease activity index, ASDAS ankylosing spondylitis disease activity score, csDMARDs conventional synthetic disease-modifying anti-rheumatic drugs, TNF-inhibitors tumor necrosis factor inhibitors
  2. asmoking and snuff use
  3. beducation level: low = elementary school, intermediate = high school/vocational education, high = college/university
  4. cat least once a month